Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calystegine B2 is a naturally occurring polyhydroxy nortropane alkaloid belonging to the class of tropane alkaloids. It is found in various plants and foods such as eggplants and potatoes and has been studied for its biological activities as a glycosidase inhibitor—specifically inhibiting enzymes like alpha-galactosidase and beta-glucosidase[7][5]. This inhibition suggests potential utility in research related to lysosomal storage disorders such as Fabry disease (alpha-galactosidase deficiency) and possibly neurodegenerative diseases including Alzheimer's and Parkinson's disease[7][1]. Its mechanism of action involves competitive inhibition of glycoside hydrolases by mimicking carbohydrate substrates due to its polyhydroxylated structure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calystegine B2.